RHY Rhythm Biosciences Limited

ASX · AU · Healthcare · Medical Devices & Supplies · rhythmbio.com

—Mkt Cap: —P/E: —1d ago

Rhythm Biosciences Limited, a medical diagnostics company, develops and commercialises medical diagnostic tests for cancer detection in Australia and the United States. The company offers ColoSTAT, a blood test for the e…

Industry Peers

Medical Devices & Supplies

Screen all

Shoulder Innovations, Inc.

$382.44MUSDP/E 23.0

TEVO

Tevano Systems Holdings Inc.

$422.8KUSD

MMEDV

MiniMed Group, Inc. Common Stock When Issued

—

Key Statistics

Company

Market Cap—

Enterprise Value14.18M USD

Revenue (TTM)1.20M USD

Gross Profit-189.78K USD

Net Income (TTM)-4.10M USD

Revenue/Share0.0050 AUD

Last Price—

Fiscal Year EndJun 2026

MR QuarterJun 2026

Employees—

CountryAU

SectorHealthcare

IndustryMedical Devices & Supplies

ISINAU000000RHY2

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-3.62

EV/Revenue11.79

P/S13.62

P/B6.70

EPS (TTM)-0.02

EPS (Forward)—

52W Range

—

52W High—

52W Low—

Profitability

Gross Margin-321.80%

Oper. Margin-3067.49%

EBITDA Margin0.00%

Profit Margin-6948.85%

ROE-163.04%

ROA-124.14%

Growth

Revenue Growth-25.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-3.62M USD

CapEx (TTM)17.83K USD

FCF Margin-188.84%

FCF Yield—

Net Debt-2.21M USD

Net Debt/EBITDA0.56

Balance Sheet

Debt/Equity0.07

Current Ratio3.60

Quick Ratio3.36

Book Value/Sh0.01 AUD

Cash/Share0.01 AUD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 AUD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.353.87M

Float255.24M

Insiders24.00%

Institutions9.83%

Technical

SMA 500.0838 AUD

SMA 2000.1324 AUD

Beta0.57

S&P 52W Chg16.44%

Avg Vol (30d)—

Avg Vol (10d)170.67K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—